On July 15, 2022, the ZAODX World Cancer Early Screening Conference was held at the Chimelong International Convention and Exhibition Center. Linaxin Biotechnology was invited to attend the conference, witnessing industry pioneers and professional scholars jointly exploring the future commercial and academic development direction of the early screening industry.

       The conference also evaluated the contributions and social influence of enterprises and their founders in the field of early screening. After multiple rounds of expert evaluation and online voting, the winners of the "Golden Screening Award" were selected and presented on-site.

Dr. Tan Shengwei, founder of Linaxin Biotechnology, has many years of exploration and practical experience in the field of cancer early screening, and has strong technical expertise in cutting-edge industries such as nanopore early screening. In this "Golden Screening Award" selection, he was awarded the title of "New Enterprise".

As a high-tech enterprise in the fields of home health self inspection and early cancer screening, Linaxin Biotechnology has formed a closed-loop system integrating research and development, production, sales, and inspection. In terms of production equipment, professional technical personnel, quality management system, after-sales service capabilities, etc., it has reached a high level in the industry.

The company's mission is to "screen one sample early, save one life, benefit one family, and improve people's health level". We aim to break through the last mile of home self inspection, deliver accurate testing to thousands of households, safeguard the health of the people, and strive to achieve the great dream of a Healthy China by 2030!